Postoperative Radiation Therapy and Adjuvant Chemoimmunotherapy in Breast Cancer Aspects of Timing and Immune Competence

References

• Adler A., Stein J. A., Ben-Efraim S. Immunocompetence, immunosuppression, and human breast cancer II and III. Cancer 1980; 45: 2061
   PubMed Web of Science ®Google Scholar
• Bolton P. M., Teasdale C., Mander A. M. Immune competence in breast cancer-relationship of pretreatment immunologic tests to diagnosis and tumor stage. Cancer Immunol. Immunother. 1976; 1: 251, et coll
   Web of Science ®Google Scholar
• Bonadonna G., Valagussa P. Chemotherapy of breast cancer. Current views and results. Int. J. Radiat. Oncol. Biol. Phys. 1983; 9: 279
   PubMed Web of Science ®Google Scholar
• Bosworth J. L., Ghossein N. A., Brook T. L. Delayed hypersensitivity in patients treated by curative radiotherapy. Its relation to tumor response and short-term survival. Cancer 1975; 36: 353
   PubMed Web of Science ®Google Scholar
• Eilber F. R., Nizze J. A., Morton D. L. Sequential evaluation of general immune competence in cancer patients. Correlation with clinical course. Cancer 1975; 35: 660
   PubMed Web of Science ®Google Scholar
• Executive committee of the Danish breast cancer co-operative group. Increased breast cancer recurrence rate after adjuvant therapy with levamisole. Lancet II 1980; 824
   Web of Science ®Google Scholar
• Fisher B., Redmond C, Brown A. (NSABP): Treatment of primary breast cancer with chemotherapy and tamoxiphen. New Engl. J. Med. 1981; 305: 1, et coll
   PubMed Web of Science ®Google Scholar
• Glas U., Wasserman J. Effect of radiation treatment on cell-mediated immune response in carcinoma of the breast. Acta radiol. Ther. Phys. Biol. 1974; 13: 83
   PubMed Web of Science ®Google Scholar
• Gröhn P., Heinonen E., Klefström P., Tarkkanen J. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. Cancer 1984; 54: 670
   PubMed Web of Science ®Google Scholar
• Hall L. S., Gordon D. S. Reproducibility, efficacy and methodology of mitogen-induced lymphocyte transformations by the whole blood assay. J. Immunol. Meth. 1976; 12: 31
   PubMed Web of Science ®Google Scholar
• Han T., Nemoto T., Ledesema E. J., Bruno S., Amery W. K. Monocyte-mediated suppression of T lymphocyte proliferative response in breast and colorectal cancer patients. Specific action of levamisole on suppressor monocytes. Int. J. Immunopharmac. 1981; 3: 103
   PubMed Web of Science ®Google Scholar
• Harris J. E., Braun D. P. Effects of adjuvant chemotherapy for stage II breast cancer on immunoregulatory cell functions. C-150. Proc. Amer. Soc. Clin. Oncol. 1981; 22: 370
   Google Scholar
• Henderson C., Canellos G. P. Cancer of the breast. The past decade. New Engl. J. Med. 1980; 302: 17
   PubMed Web of Science ®Google Scholar
• Høst H., Brennhovd I. O. The effect of postoperative radiotherapy in breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1977; 2: 1061
   PubMed Web of Science ®Google Scholar
• Kay R. G., Mason B. H., Stephens A. J. Levamisole in primary breast cancer. A controlled study in conjunction with L-phenylalanine mustard. Cancer 1983; 51: 1992, et coll.
   PubMed Web of Science ®Google Scholar
• Klefström P. Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer. Cancer Treat. Rep. 1980; 64: 65
   PubMedGoogle Scholar
• Klefström P., Holsti P., Gröhn P., Heinonen E., Holsti L. Levamisole in the treatment of stage II breast cancer. Five-year follow-up of a randomized double-blind study. Cancer 1985; 55: 2753
   PubMed Web of Science ®Google Scholar
• Mackay I. R., Goodyear M. D. E., Riglar C., Penschow J. Effect on natural killer and antibody-dependent cellular cytotoxicity of adjuvant cytotoxic chemotherapy including melphalan in breast cancer. Cancer Immunol. Immunother. 1983; 16: 98
   PubMed Web of Science ®Google Scholar
• Mathe G. Innune status and cancer chemotherapy efficacy. Cancer Immunol. Immunother. 1977; 2: 81
   Web of Science ®Google Scholar
• Park S. K., Brody J. I., Wallace H. A., Blakemore W. S. Immunosuppressive effect of surgery. Lancet I 1971; 53
   PubMedGoogle Scholar
• Peto R., Pike M. C., Armitage P. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. I. Introduction and design. Brit. J. Cancer 1977; 34: 585, et coll., 1976
   Web of Science ®Google Scholar
• Brit. J. Cancer, 35: 1, II. Analysis and examples.
   PubMed Web of Science ®Google Scholar
• Petrini B., Wasserman J., Baral E., Blomgren H, Strender L. E. Adjuvant radiation therapy compared with cyclic chemotherapy in patients with mammary carcinomas. I. Changes of blood lymphocyte subpopulations. Acta radiol. Oncology 1981; 20: 137
   PubMed Web of Science ®Google Scholar
• Raben M., Walach N., Galili U., Schlesinger M. The effect of radiation therapy on lymphocyte subpopulations in cancer patients. Cancer 1976; 37: 1417
   PubMed Web of Science ®Google Scholar
• Rojas A., Mickiewitz E., Feierstein J., Glatt H., Olivari A. Levamisole in advanced human breast cancer. Lancet 1980; 18: 824
   Google Scholar
• Stjernswärd J. Adjuvant radiotherapy trials in breast cancer. Cancer 1977; 39: 1316
   Web of Science ®Google Scholar
• Strender L E., Blomgren H., Petrini B. Immunologic monitoring in breast cancer patients receiving postoperative adjuvant chemotherapy. Cancer 1981; 48: 1996, et coll
   PubMed Web of Science ®Google Scholar
• Tage T., Hamamoto S., Itagaki E. Concanavalin A-induced and spontaneous suppressor cell activities in peripheral blood lymphocytes and spleen cells from gastric cancer patients. Cancer 1983; 52: 1624, et coll
   PubMed Web of Science ®Google Scholar
• Toianen A., Nordman E. Long-term effect of postoperative irradiation on the immune functions in patients with mammary carcinoma. Acta radiol. Oncology 1981; 20: 119
   PubMedGoogle Scholar
• Vogel C. L., Silverman M. A., Mansell P. W. Mechanism of levamisole-induced granulocytopenia in breast cancer patients. Amer. J. Hematol. 1980; 9: 171, et coll
   PubMed Web of Science ®Google Scholar
• Wallgren A., Arner O., Bergström I. Preoperative radiotherapy in operable breast cancer. Results in the Stockholm breast cancer trial. Cancer 1978; 42: 1120, et coll
   PubMed Web of Science ®Google Scholar